1Liang MH, Mahdl LA, Costenbader K, et al. Atherosclerotic vascular disease in systemic lupus erythematosus. J Natl Med Assoc, 2002,94:813-819.
2Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematosus: quantification olr degrees olr narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med ,1981,70 : 775-781.
3Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy.Am J Med , 1975,58:243-264.
4MacGregor AJ, Dhillon VB, Binder A, et al. Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus. Ann Rheum Dis,1992,51:152-155.
5Romero FI, Atsumi T, Tinahones FJ, et al. Autoantibodies against malondialdehyde-modified lipoprotein (a) in antiphospholipid syndrome. Arthritis Rheum, 1999,42:2606-2611.
6Landewe RB, van den Borne BE, Breedveld FC, et al.Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet ,2000,355:1616-1617.
7Rahman P, Urowitz MB, Gladman DD, et al. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol, 1999, 26: 2363-2368.
8Ura M, Sakata R, Nakayama Y, et al. Coronary artery bypass grafting in patients with systemic lupus erythematosus. Eur J Cardiothorae Surg , 1999,15:697-701.
9Rangel A, Lavalle C, Chavez E, et al. Myocardial infarction in patients with systemic lupus erythematosus with normal findings from coronary arteriography and without coronary vasculitis case reports. Angiololgy, 1999,50:245-253.
10Morton KE, Gavaghan TP, Krilis SA, et al. Coronary artery bypass graft failure-an autoimmune phenomenon? Lancet, 1986,2:1353-1357.
5Sarkissian T, Beyenne J, Feldman B , et al. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus[ J]. Arthrities Rheum,2006,54 (4) : 1283 - 1290.
6Ettinger WH, Goldberg AP, Applebaum Bowden D, et al. Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids[ J]. Am J Med,1987,83(3) :503 -508.
7Svens0n KL, Lundqvist G, Wide L, et al. Impaired glucose handling in active rheumatoid arthritis, effects of corticosteroids and antirheumatic treatment [J ]. Metabolism, 1987,36 ( 10 ) - 944 - 948.
8Petri M. Detection of coronary artery disease and the role of tradi- tional risk factors in the Hopkins Lupus Cohort [ J ] Lupus,2000,9 (3) :170 - 175.
9Bazzan M, Vaccarino A, Marletto F. Systemic lupus erythematosus and thrombosis[ J]. Thromb J ,2015,13 : 16.
10Skaggs B J, Hahn BH, McMahon M. Accelerated atherosclerosis in patients with SLE - mechanisms and management [ J ]. Nat Rev Rheumatol,2012,8 (4) : 214 - 223.
